PT-141 (Bremelanotide) – Research Peptide
PT-141, also known as Bremelanotide, is a synthetic peptide analog derived from α-MSH (alpha-melanocyte-stimulating hormone). In research settings, PT-141 is primarily studied for its interaction with melanocortin receptors (MC3R & MC4R), which are involved in central nervous system signaling rather than peripheral vascular pathways.
Unlike PDE-5 inhibitors, PT-141 has been shown in research models to act centrally within the brain, making it a unique compound of interest for studies involving neuroendocrine signaling, motivation pathways, and behavioral response mechanisms.
PT-141 has been investigated in both male and female research models, with particular focus on central arousal signaling, hypothalamic activation, and melanocortin pathway modulation. Ongoing research continues to explore its effects on neurotransmitter release and neural responsiveness.
This product is supplied strictly for laboratory and research purposes only.
Key Research Areas
-
Melanocortin receptor activation (MC3R / MC4R)
-
Central nervous system signaling pathways
-
Neuroendocrine and hypothalamic response studies
-
Behavioral and motivational pathway research
-
Sexual dimorphism in CNS response models
Product Details
-
Peptide Name: PT-141 (Bremelanotide)
-
Form: Lyophilised powder
-
Purity: ≥99% (HPLC tested)
